1 BTC
=
- USD
Greenland Mines Ltd. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Market Statistics
Trading Metrics
How to Buy GRML
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy GRML
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesWestern governments are mobilizing capital around critical minerals supply security. Greenland Mines' Skaergaard PGM-gold deposit in Southeast Greenland, valued at approximately $68 billion, is advancing from technical study to active project execution. The deposit contains 25.4 Moz palladium-equivalent and 23.5 Moz gold-equivalent, equivalent to 13-15 years of U.S. palladium consumption. Other Western critical minerals developers including NioCorp, MP Materials, Critical Metals, and USA Rare Earth are also advancing projects amid rising palladium and rare earth prices and increased government support.
Greenland Mines Ltd. (NASDAQ:GRML) acquired the Sarfartoq rare earth project in Greenland from Neo Performance Materials for US$35 million. The project is rich in neodymium and praseodymium, critical for EV motors and wind turbines. Neo retains an equity stake and offtake rights for up to 60% of future production, validating the project's strategic importance as Western nations seek to reduce dependence on Chinese rare earth supply.
Greenland Mines Ltd has signed a definitive agreement to acquire the Sarfartoq rare earths project in Greenland for $35 million ($20M cash, $15M in stock). Neo Performance Materials becomes a strategic shareholder with offtake rights for up to 60% of future production. The acquisition adds a neodymium and praseodymium-rich asset to complement Greenland Mines' existing Skaergaard project, strengthening its position in critical minerals supply chains.
Senior gold producers are reporting record financial metrics as realized gold prices reach $4,800-$4,900/oz, up from $1,800/oz in 2022. This repricing is revaluing undeveloped gold assets significantly. Greenland Mines' Skaergaard Project shows 45-55% grade uplift in sensitivity analysis under higher price scenarios. Major producers including Newmont, Barrick, Agnico Eagle, and Kinross are unlocking value through restructurings and asset repricings.
Greenland Mines Ltd. announced results of an independent metal-price sensitivity analysis on its Skaergaard Project in Greenland, showing palladium-equivalent (PdEq) grade increases of 45% for Indicated and 55% for Inferred resources under higher gold price assumptions ($5,000/oz Au vs. $1,800/oz in 2022 base case). The analysis, performed by SLR Consulting on the existing 2022 resource model without changing tonnages or cutoff grades, indicates 16.58 Moz PdEq Indicated and 21.92 Moz PdEq Inferred in the high-price sensitivity case. The company plans a fully funded 2026 program to evaluate open-pit and bulk-mining scenarios alongside underground concepts.
